RDWM
DGX icon

Red Door Wealth Management’s Quest Diagnostics DGX Stock Holding History

Red Door Wealth Management’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Buy
3,024
+4
+0.1% +$785 0.06% 160
2026
Q1 		$592K Sell
3,020
-7
-0.2% -$1.36K 0.06% 153
2025
Q4 		$525K Buy
3,027
+4
+0.1% +$728 0.05% 154
2025
Q3 		$576K Buy
3,023
+3
+0.1% +$532 0.06% 149
2025
Q2 		$542K Hold
3,020
– – 0.06% 152
2025
Q1 		$511K Sell
3,020
-150
-5% -$24.6K 0.08% 133
2024
Q4 		$478K Buy
+3,170
New +$493K 0.07% 140

Other funds holding DGX

Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
ECSS
Eurizon Capital SGR SpA Milan $37.3B AUM
EB
Eastern Bank Boston, Massachusetts $6.53B AUM 30.05% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $26.6B AUM
CPC
Cookson Peirce & Co Pittsburgh, Pennsylvania $3.04B AUM 94.11% 1-Year Est. Return

Red Door Wealth Management's DGX Position: Q2 2026 in Review

Red Door Wealth Management increased its Quest Diagnostics (DGX) stake by 0.13% in Q2 2026, buying an estimated $785 and bringing the position to 3,024 shares worth $641K. The position accounts for 0.06% of the portfolio, ranked #160.

Red Door Wealth Management first reported a position in DGX in Q4 2024 and has held it in 7 quarters since. 503 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Red Door Wealth Management held 3,024 shares of Quest Diagnostics worth $641K as of Q2 2026.
  • Red Door Wealth Management bought 4 Quest Diagnostics shares in Q2 2026, an estimated $785.
  • Quest Diagnostics made up 0.06% of Red Door Wealth Management's portfolio in Q2 2026, its #160 holding.
  • Red Door Wealth Management first reported a position in Quest Diagnostics in Q4 2024 and has held it in 7 quarters since.
  • 503 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Red Door Wealth Management's 13F filing for Q2 2026, filed 13 Jul 2026.